NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









GeneFab

GeneFab

Private
Alameda, CaliforniaHealthcare & Life Scienceshttps://genefab.com/

Last Round

Private Equity

Aug 10, 2023

Company Overview

GeneFab is a biotechnology company that operates as a contract development and manufacturing organization (CDMO) providing integrated services for cell and gene therapy design, development, and cGMP manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

CRDMOcontract research and manufacturing organizationcell and gene therapyCDMOsynthetic biologybiofoundrycGMP manufacturingviral vector manufacturingnucleic acid manufacturinggenetic designbiotech outsourcingdrug development partnerprocess developmentcell bankingbioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GeneFab Comparables

Compare GeneFab with similar companies based on industry and business-model similarity.

GeneFab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Resilience
80%
ElevateBio
80%
Ajinomoto Co. Inc
78%

GeneFab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityAug 10, 2023

Key People

Founding team and executive leadership

Philip Lee

Chief Executive Officer

Executive Team

GeneFab Investors

Notable investors and investment history

GeneFab investors
InvestorRounds
Celadon PartnersPrivate Equity
K5 GlobalPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors increased 245% MoM, reaching 1.7K.

  • Nov 10, 2025

    Monthly visitors increased 33% MoM.

GeneFab Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GeneFab Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GeneFab's valuation, stock price, and market status.

Firmographic Details

HeadquartersAlameda, California
Employee Range56
Year Founded2023
Last FundingAug 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.